Play all audios:
Access through your institution Buy or subscribe Hypertension and diabetes are major risk factors for cardiovascular disease (CVD).1, 2 Hypertension is the single most important risk factor
for ischemic and a major risk factor for hemorrhagic stroke, in addition to coronary heart disease (CHD).1 Similarly, patients with diabetes have a two- to four-fold higher risk of CVD, the
leading cause of death in this population.2 Also associated with CVD are the often un(der)diagnosed conditions of pre-hypertension3 and pre-diabetes,4 which often evolve to full disease. A
better understanding of the risks associated with these precursor conditions is essential—including in regions where hypertension and especially diabetes are rising at rates not even seen in
(high-risk) Western countries. The report by Khosravi and colleagues in this issue of the _Journal_ fills a significant gap and sets the stage for further explorations in Arab-speaking
countries tied by language, heritage and religion.5 Using the Ishafan Cohort Study, an elegantly designed survey with random multistage cluster sampling, the authors examine the independent
and joint associations of pre-diabetes and pre-hypertension with subsequent onset of major cardiac outcomes. Summarized, in age- and gender-adjusted analyses, pre-hypertension was predictive
of unstable angina and CVD, and comorbid pre-hypertension and pre-diabetes predictive of myocardial infarction. Pre-diabetes was not independently associated with cardiovascular events. The
authors also compare their rates to those in other Middle-Eastern countries—showing similarities and differences in results across studies that vary in methodology. Together, this gives a
convincing epidemiological perspective on the association of pre-hypertension and pre-diabetes with cardiovascular morbidity and mortality in Iran; and an initial view on the epidemiological
dynamics in other countries in the region. This is particularly pertinent given the epidemiology of hypertension and diabetes in the Arab-speaking region. This is a preview of subscription
content, access via your institution RELEVANT ARTICLES Open Access articles citing this article. * PREVALENCE OF HYPERTENSION AND ASSOCIATED FACTORS: A CROSS-SECTIONAL STUDY IN RIYADH, SAUDI
ARABIA * Seema Mohammed Nasser * , Mamdouh M. Shubair * … Ashraf El-Metwally _BMC Health Services Research_ Open Access 07 March 2025 ACCESS OPTIONS Access through your institution
Subscribe to this journal Receive 12 digital issues and online access to articles $119.00 per year only $9.92 per issue Learn more Buy this article * Purchase on SpringerLink * Instant
access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions *
Read our FAQs * Contact customer support REFERENCES * World Heart Federation. Cardiovascular disease risk factors: hypertension. World Heart Federation: Geneva, Switzerland, 2016. Available
at: http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/hypertension/. Accessed on 9 September 2016. * World Heart Federation. Cardiovascular
disease risk factors: diabetes. World Heart Federation: Geneva, Switzerland, 2016. Available at:
http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/diabetes/. Accessed on 9 September 2016. * Elliott WJ, Black HR . Prehypertension. _Nat Clin
Pract Cardiovasc Med_ 2007; 4: 538–548. Article Google Scholar * Menke A, Casagrande S, Geiss L, Cowie CC . Prevalence of and trends in diabetes among adults in the United States,
1988-2012. _JAMA_ 2015; 314: 1021–1029. Article CAS Google Scholar * Khosravi A, Gharipour M, Nezafati P, Khosravi Z, Sadeghi M, Khaledifar A _et al_. Pre-hypertension, pre-diabetes or
both: which is best at predicting cardiovascular events in the long-term? _J Hum Hypertens_ (e-pub ahead of print 23 June 2016; doi: 10.1038/jhh.2016.42). * Sarnak MJ, Levey AS, Schoolwerth
AC, Coresh J, Culleton B, Hamm LL _et al_. Kidney disease as a risk factor for development of cardiovascular disease. _Circulation_ 2003; 108: 2154–2169. Article Google Scholar * United
States Renal Data System. Cardiovascular disease in patients with CKD. _Am J Kidn Dis_ 2016; 67 (suppl 1): S49–S56. Google Scholar * United States Renal Data System. Cardiovascular disease
in patients with ESRD. _Am J Kidn Dis_ 2016; 67 (suppl 1): S259–S268. Google Scholar * Farag YMK, Gaballa MR . Diabesity: an overview of a rising epidemic. _Nephrol Dial Transplant_ 2011;
26: 28–35. Article Google Scholar * World Health Organization. Health statistics and information systems. Disease and injury country estimates. Burden of disease. Death and DALY estimates
for 2004 by cause for WHO Member States. Persons, all ages. WHO: Geneva, Switzerland. Available at: http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/. Accessed on 9
September 2016. * Murray CJL . Quantifying the burden of disease: the technical base for disability-adjusted life years. _Bull World Health Org_ 1994; 72: 429–445. CAS PubMed Google
Scholar * World Health Organization. Global Health Observatory data repository. Obesity (body mass index >=30) (age-standardized estimate). Data by country. WHO: Geneva, Switzerland.
Available at: http://apps.who.int/gho/data/node.main.A900A?lang=en. Accessed on 9 September 2016. * Farag YMK, Kari JA, Singh AK . Chronic kidney disease in the Arab world: a call for
action. _Nephron Clin Pract_ 2012; 121: c120–c123. PubMed Google Scholar * United States Renal Data System. Incidence, prevalence, patient characteristics, and treatment modalities. _Am J
Kidn Dis_ 2016; 67 (suppl 1): S139–S158. Google Scholar * Abraham I, Bootman JL . Why pharmacoeconomic policy should be transnational. _Pharm Policy Law_ 2012; 14: 7–16. Google Scholar
Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA I Abraham & S Kurdi *
Matrix45, Tucson, AZ, USA I Abraham & K MacDonald * College of Pharmacy, University of Dammam, Dammam, Saudi Arabia S Kurdi Authors * I Abraham View author publications You can also
search for this author inPubMed Google Scholar * S Kurdi View author publications You can also search for this author inPubMed Google Scholar * K MacDonald View author publications You can
also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to I Abraham. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no conflict of interest.
RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Abraham, I., Kurdi, S. & MacDonald, K. The hypertension, diabetes and chronic kidney disease triangle
in Arab countries. _J Hum Hypertens_ 31, 373–375 (2017). https://doi.org/10.1038/jhh.2017.16 Download citation * Published: 23 March 2017 * Issue Date: June 2017 * DOI:
https://doi.org/10.1038/jhh.2017.16 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently
available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative